Jpmorgan Chase & CO Prokidney Corp Ord Shs Cl A(Cy Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Jpmorgan Chase & CO holds 28,358 shares of PROK stock, worth $43,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,358
Previous 20,812
36.26%
Holding current value
$43,954
Previous $34,000
102.94%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PROK
# of Institutions
72Shares Held
40MCall Options Held
644KPut Options Held
118K-
Morgan Stanley New York, NY14.4MShares$22.4 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.34MShares$14.5 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.98MShares$6.16 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$5.67 Million0.0% of portfolio
-
Bleichroeder LP New York, NY2.61MShares$4.05 Million2.32% of portfolio
About PROKIDNEY CORP ORD SHS CL A(CY
- Ticker PROK
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,540,200
- Market Cap $95.4M